Results 281 to 290 of about 482,975 (382)

A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy. [PDF]

Transl Cancer Res
Li HX, Song LH, Chen YH, Zhao J, Zhang XF.   +4 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Gross haematuria in the era of anticoagulant therapy - Implications on treatment and diagnostic approaches in a large emergency department patient population. [PDF]

BJUI Compass
Yang Y, Seidl J, Engelmann SU, Haas M, Mayr R, Burger M, Breyer J, Resch M.   +7 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Influence of heparin-based anticoagulants on antibiotic therapy. [PDF]

Front Immunol
Cont D, Schildböck C, Kolm C, Kirschner AKT, Farnleitner AH, Hartmann J, Weber V, Harm S.   +7 more
europepmc   +1 more source

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

Thrombosis and Haemostasis, 2016
V. Raparelli, Marco Proietti, R. Cangemi, G. Lip, D. Lane, S. Basili   +5 more
semanticscholar   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Oral anticoagulant reversal and mortality in trauma patients: a multicentre propensity score-matched cohort study. [PDF]

EClinicalMedicine
Lang E, Gautier M, Hanouz JL, Vardon F, Legros V, Duclos G, Hericher F, Audibert G, Huet-Garrigue D, Abback PS, Popoff B, Duranteau O, Figueiredo S, Allain PA, Botrel T, Pasqueron J, Godier A, Traumabase® Group.   +17 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluation of Peptidomimetic Inhibitors of Factor XIa as Novel Anticoagulants

, 2006
Jian Lin, Hongfeng Deng, Lei Jin, Pramod S. Pandey, Jesse Quinn, Susan Cantin, Michael J. Rynkiewicz, Joan C. Gorga, F. Bibbins, Cassandra A. Celatka, Pamela Nagafuji, Thomas D. Bannister, Harold V. Meyers, Robert E. Babine, Neil J. Hayward, David T. Weaver, Howard W. Benjamin, F L Stassen, Sherin S. Abdel‐Meguid, James E. Strickler   +19 more
openalex   +1 more source